Head-To-Head Analysis: Allurion Technologies (NYSE:ALUR) & Apyx Medical (NASDAQ:APYX)

Allurion Technologies (NYSE:ALUR) and Apyx Medical (NASDAQ:APYX) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, risk and institutional ownership.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Allurion Technologies and Apyx Medical, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Allurion Technologies	1	1	1	0	2.00
Apyx Medical	1	1	3	1	2.67

Allurion Technologies currently has a consensus target price of $3.00, indicating a potential upside of 341.18%. Apyx Medical has a consensus target price of $6.50, indicating a potential upside of 122.60%. Given Allurion Technologies’ higher possible upside, analysts plainly believe Allurion Technologies is more favorable than Apyx Medical.

Earnings & Valuation

This table compares Allurion Technologies and Apyx Medical”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Allurion Technologies	$17.21 million	0.59	-$7.20 million	($10.56)	-0.06
Apyx Medical	$52.84 million	2.31	-$11.21 million	($0.27)	-10.81

Allurion Technologies has higher earnings, but lower revenue than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Allurion Technologies, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Allurion Technologies and Apyx Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Allurion Technologies	-199.96%	N/A	-77.13%
Apyx Medical	-21.22%	-114.95%	-18.49%

Institutional & Insider Ownership

21.4% of Allurion Technologies shares are owned by institutional investors. Comparatively, 55.3% of Apyx Medical shares are owned by institutional investors. 8.1% of Allurion Technologies shares are owned by company insiders. Comparatively, 15.2% of Apyx Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Risk and Volatility

Allurion Technologies has a beta of -0.18, suggesting that its share price is 118% less volatile than the S&P 500. Comparatively, Apyx Medical has a beta of 1.35, suggesting that its share price is 35% more volatile than the S&P 500.

Summary

Apyx Medical beats Allurion Technologies on 11 of the 15 factors compared between the two stocks.

About Allurion Technologies

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.

About Apyx Medical

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.